Equities

Progyny Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
PGNY:NSQ

Progyny Inc

Actions
Health CareHealth Care Providers
  • Price (USD)17.79
  • Today's Change0.270 / 1.54%
  • Shares traded2.39m
  • 1 Year change-17.49%
  • Beta1.0047
Data delayed at least 15 minutes, as of Mar 04 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.

  • Revenue in USD (TTM)1.29bn
  • Net income in USD58.52m
  • Incorporated2008
  • Employees856.00
  • Location
    Progyny Inc1359 Broadway, 2Nd FloorNEW YORK 10018United StatesUSA
  • Phone+1 (212) 888-3124
  • Fax+1 (302) 636-5454
  • Websitehttps://www.progyny.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
OPKO Health Inc606.88m-225.68m903.29m2.28k--0.7124--1.49-0.3021-0.30210.80771.670.29376.545.83266,759.60-10.92-7.51-11.90-8.4333.9332.49-37.18-16.633.52-6.220.2159---14.90-15.82-324.02---18.28--
Teladoc Health Inc2.53bn-200.32m909.82m5.60k--0.65635.560.3596-1.14-1.1414.367.770.793720.2112.43451,781.60-6.28-38.49-7.97-41.0069.5069.71-7.92-127.752.67--0.4179---1.5418.2679.99--43.24--
Clover Health Investments Corp1.92bn-85.55m1.05bn724.00--3.36--0.5453-0.1662-0.16623.780.59483.43--26.292,657,884.00-15.25-32.81-24.46-53.70-----4.45-16.62----0.00--40.34---84.91------
Pennant Group Inc947.71m29.58m1.14bn9.70k39.443.4427.061.210.83730.837326.839.611.15--9.2797,701.554.102.715.053.2419.7520.273.562.63--8.520.31720.0036.3119.3731.1113.4424.85--
Astrana Health Inc2.90bn9.54m1.23bn1.90k129.221.5626.040.42440.18970.189759.2315.701.64--9.821,524,450.000.55286.980.64968.4610.2516.790.33625.34--2.780.65439.3446.7229.41-28.9325.0450.46--
NeoGenomics, Inc.727.33m-108.03m1.24bn2.50k--1.47--1.70-0.844-0.8445.686.490.485214.934.69290,932.80-7.21-5.27-8.28-5.7443.2141.16-14.85-14.373.94--0.2901--10.1110.35-37.22---1.48--
US Physical Therapy Inc780.99m21.57m1.26bn4.20k58.552.6415.661.611.421.4251.4731.500.6587--8.98185,950.004.895.187.477.6119.2020.267.437.80--12.090.174292.3916.3313.05-22.20-7.4612.99--
InnovAge Holding Corp915.37m6.47m1.29bn2.44k203.915.0258.291.410.04650.04656.741.891.74--25.76375,152.500.6333-5.800.9505-7.8720.3419.120.364-4.25--6.500.1927--11.768.52-42.06---11.96--
Ardent Health Inc6.33bn205.06m1.35bn19.20k6.471.093.000.2131.451.4544.838.651.2723.158.82329,455.705.96--8.08--57.94--4.69--1.957.420.404--10.29--290.22------
Progyny Inc1.29bn58.52m1.43bn856.0026.862.8322.611.110.65220.652214.366.191.91--5.661,505,445.008.679.8111.9613.4823.6322.274.545.61----0.000.0010.4030.177.704.7277.77--
Lumexa Imaging Holdings Inc1.00bn-43.47m1.46bn4.06k--8.75--1.46-0.4597-0.459710.611.77------246,893.50--------13.66---4.33----0.53320.8806--1.38--23.01------
Aveanna Healthcare Holdings Inc2.29bn75.46m1.52bn3.50k19.79153.4117.740.6640.36780.367811.010.04751.33--7.69654,454.604.37-10.765.72-13.0033.5731.323.29-11.05--1.830.9933--6.827.9091.88---17.60--
Pediatrix Medical Group Inc1.91bn165.39m1.64bn2.30k10.181.898.750.85611.941.9422.4510.430.87--7.82833,921.107.521.449.431.75----8.641.80--17.390.40820.00-4.921.99266.94---8.51--
Surgery Partners Inc3.31bn-77.90m1.80bn16.00k--1.056.550.5442-0.6131-0.613126.0113.250.413326.555.60206,793.801.241.181.781.6625.7826.272.992.901.712.010.5121--6.2412.2153.66--12.90--
Addus Homecare Corporation1.42bn95.91m1.91bn5.29k19.811.7617.041.355.225.2277.4158.610.9983--10.36268,909.306.735.897.546.7532.4732.236.745.93--12.410.10030.0023.2113.2230.3223.692.47--
Data as of Mar 04 2026. Currency figures normalised to Progyny Inc's reporting currency: US Dollar USD

Institutional shareholders

45.65%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Dec 202511.12m12.89%
The Vanguard Group, Inc.as of 31 Dec 20258.97m10.41%
Fidelity Management & Research Co. LLCas of 31 Dec 20254.44m5.15%
SSgA Funds Management, Inc.as of 31 Dec 20252.95m3.43%
Citadel Advisors LLCas of 31 Dec 20252.16m2.51%
FIAM LLCas of 31 Dec 20252.13m2.47%
Geode Capital Management LLCas of 31 Dec 20251.97m2.29%
Thrivent Asset Management LLCas of 31 Dec 20251.90m2.20%
Threadneedle Asset Management Ltd.as of 31 Dec 20251.88m2.18%
Fort Washington Investment Advisors, Inc.as of 31 Dec 20251.83m2.13%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.